Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.

Published Date: 15 Jan 2024

One of the true benefits of the non-covalent BTK inhibitor, according to the panelist, is its safety profile.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

One-third of childhood cancer survivors experience significant fear that it could come back, study reveals

2.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

3.

Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A

4.

For the first time in humans, a chemotherapy drug reaches the brain.

5.

Health of Myeloma Patient's Marriage Tied to Recovery After Transplant


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot